ELKAN R GAMZU Insider Trading
Get free email notifications about insider trading for ELKAN R GAMZU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ELKAN R GAMZU. ELKAN R GAMZU is a CEO designate in PHARMOS CORP ($PARS) and an Chief Executive Officer in PHARMOS CORP ($PARS) and a Director in PHARMOS CORP ($PARS).
Address: C/O PHARMOS CORPORATION 99 WOOD AVENUE SOUTH, SUITE 311 ISELIN 08830 NJ
Companies in which ELKAN R GAMZU is an Insider
PHARMOS CORP
Trading Symbol: PARSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ELKAN R GAMZU: Chief Executive Officer, CEO designate, Director
Holdings: 2,000 shares
Current Value: $40
Latest Transaction: Jul 02 2008
$PARS Market Capitalization: $1.11M
$PARS Previous Close: $0.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ELKAN R GAMZU
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2008 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 0.39 | 20,000 | 7,800 | 20,000 | |
Jan 25 2008 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 0.35 | 20,000 | 7,000 | 20,000 | |
Oct 26 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | Chief Executive Off ... | Option Exercise | A | 1.46 | 200,000 | 292,000 | 200,000 | |
Apr 03 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | Chief Executive Off ... | Option Exercise | A | 1.46 | 200,000 | 292,000 | 200,000 | |
Feb 28 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | CEO designate | Option Exercise | A | 1.55 | 150,000 | 232,500 | 150,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 |